BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Zhao W, Liu Y, Tan X, Li X, Zou Q, Xiao Z, Xu H, Wang Y, Yang X. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. EMBO J 2018;37:e99017. [PMID: 30158112 DOI: 10.15252/embj.201899017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 70] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Wu S, Yang X, Qiu X, Pan Y, Bhattacharya S. Fuzzy Data Mining and Bioinformatics Analysis in Methylation Analysis of M6A Gene Promoter Region in Esophageal Cancer. Journal of Sensors 2022;2022:1-12. [DOI: 10.1155/2022/4420717] [Reference Citation Analysis]
2 Wang N, Xu Y, Jin L, Wang X, Wu S, Wang Y, Zhao J, Zhou F, Ge H, Zhang Z. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma. Disease Markers 2022;2022:1-24. [DOI: 10.1155/2022/1829528] [Reference Citation Analysis]
3 Arancio W, Coronnello C. Repetitive Sequence Transcription in Breast Cancer. Cells 2022;11:2522. [PMID: 36010599 DOI: 10.3390/cells11162522] [Reference Citation Analysis]
4 Shen Z, Shao YL, Liu W, Zhang Q, Yuan L. Prediction of Back-splicing sites for CircRNA formation based on convolutional neural networks. BMC Genomics 2022;23:581. [PMID: 35962324 DOI: 10.1186/s12864-022-08820-1] [Reference Citation Analysis]
5 Hu X, Zou Q, Yao L, Yang X. Survey of the binding preferences of RNA-binding proteins to RNA editing events. Genome Biol 2022;23:169. [PMID: 35927743 DOI: 10.1186/s13059-022-02741-8] [Reference Citation Analysis]
6 Li Y, Wang H, Wan J, Ma Q, Qi Y, Gu Z. The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma. Front Oncol 2022;12:845931. [DOI: 10.3389/fonc.2022.845931] [Reference Citation Analysis]
7 Yao W, Hou J, Liu G, Wu F, Yan Q, Guo L, Wang C. LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway. Mol Ther Oncolytics 2022;25:189-200. [PMID: 35592388 DOI: 10.1016/j.omto.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Z, Wang S, Pang L, Meng X. circXRCC5 foster gastric cancer growth and metastasis by the HNRNPC/circXRCC5/miR-655-3p/RREB1/UBA2 positive feedback loop. Cancer Gene Ther. [DOI: 10.1038/s41417-022-00482-1] [Reference Citation Analysis]
9 Solomon PE, Kirkemo LL, Wilson GM, Leung KK, Almond MH, Sayles LC, Sweet-Cordero EA, Rosenberg OS, Coon JJ, Wells JA. Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation. Mol Cell Proteomics 2022;21:100247. [PMID: 35594991 DOI: 10.1016/j.mcpro.2022.100247] [Reference Citation Analysis]
10 Liu T, Li H, Du G, Ma J, Shen J, Zhao H, Luo F, Li H. Comprehensive analysis of m6A regulator-based methylation modification patterns characterized by distinct immune profiles in colon adenocarcinomas. Gene 2022;821:146250. [PMID: 35151825 DOI: 10.1016/j.gene.2022.146250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wu J, Wei Y, Miao C, Wang S, Wang X, Wang Z, Wang J. Essential m6A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma. Journal of Oncology 2022;2022:1-29. [DOI: 10.1155/2022/9411692] [Reference Citation Analysis]
12 Yang N, Liu L, Liu X, Chen Y, Lu J, Wang Z, Shi W. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/6319685] [Reference Citation Analysis]
13 Xia N, Yang N, Shan Q, Wang Z, Liu X, Chen Y, Lu J, Huang W, Wang Z. HNRNPC regulates RhoA to induce DNA damage repair and cancer‐associated fibroblast activation causing radiation resistance in pancreatic cancer. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17254] [Reference Citation Analysis]
14 Wang Y, Zhao X, Li J, Wang X, Hu W, Zhang X. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. Technol Cancer Res Treat 2022;21:15330338221085373. [PMID: 35343834 DOI: 10.1177/15330338221085373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Quan W, Li J, Liu L, Zhang Q, Qin Y, Pei X, Chen J. Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease. Parkinsons Dis 2021;2021:9919129. [PMID: 34966539 DOI: 10.1155/2021/9919129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Xing S, Wang J, Wu R, Hefti MM, Crary JF, Lu Y. Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry. RNA Biology. [DOI: 10.1080/15476286.2021.2015175] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Liu R, Shen Y, Hu J, Wang X, Wu D, Zhai M, Bai J, He A. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma. Front Oncol 2021;11:731957. [PMID: 34804925 DOI: 10.3389/fonc.2021.731957] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Qin Q, Fang DL, Zhou W, Meng Y, Wei J. Classification and immune invasion analysis of breast cancer based on m6A genes. Ann Transl Med 2021;9:1418. [PMID: 34733970 DOI: 10.21037/atm-21-3404] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Wang S, Xu G, Chao F, Zhang C, Han D, Chen G. HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer. Cancer Manag Res 2021;13:7263-76. [PMID: 34584453 DOI: 10.2147/CMAR.S330713] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Gokhale NS, Smith JR, Van Gelder RD, Savan R. RNA regulatory mechanisms that control antiviral innate immunity. Immunol Rev 2021;304:77-96. [PMID: 34405416 DOI: 10.1111/imr.13019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li L, Xie R, Wei Q. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer. PeerJ 2021;9:e11893. [PMID: 34395102 DOI: 10.7717/peerj.11893] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Herzner AM, Khan Z, Van Nostrand EL, Chan S, Cuellar T, Chen R, Pechuan-Jorge X, Komuves L, Solon M, Modrusan Z, Haley B, Yeo GW, Behrens TW, Albert ML. ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses. J Exp Med 2021;218:e20201833. [PMID: 34297039 DOI: 10.1084/jem.20201833] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Yu Z, Feng S, Zhang D, Cao X, Yu Y, Wang X. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02090-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Huang XT, Li JH, Zhu XX, Huang CS, Gao ZX, Xu QC, Zhao W, Yin XY. HNRNPC impedes m6A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma. Cancer Lett 2021;518:196-206. [PMID: 34271104 DOI: 10.1016/j.canlet.2021.07.016] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Xu Y, He X, Deng J, Xiong L, Li Y, Zhang X, Chen W, Liu X, Xu X. Comprehensive Analysis of the Immune Infiltrates and PD-L1 of m6A RNA Methylation Regulators in Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:681745. [PMID: 34277622 DOI: 10.3389/fcell.2021.681745] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
26 Li Z, Zhang P, Feng F, Zhang Q. Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics. Comb Chem High Throughput Screen 2020;23:411-8. [PMID: 32233998 DOI: 10.2174/1386207323666200401103353] [Reference Citation Analysis]
27 Fang R, Ye L, Shi H. Understanding the roles of N6-methyladenosine writers, readers and erasers in breast cancer. Neoplasia 2021;23:551-60. [PMID: 34000587 DOI: 10.1016/j.neo.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Front Immunol 2021;12:669750. [PMID: 34054840 DOI: 10.3389/fimmu.2021.669750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang W, Xu SW, Zhu XY, Guo QY, Zhu M, Mao XL, Chen YH, Li SW, Luo WD. Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma. Front Genet 2021;12:665173. [PMID: 33981333 DOI: 10.3389/fgene.2021.665173] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Ferrari R, Grandi N, Tramontano E, Dieci G. Retrotransposons as Drivers of Mammalian Brain Evolution. Life (Basel) 2021;11:376. [PMID: 33922141 DOI: 10.3390/life11050376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Xu F, Guan Y, Ma Y, Xue L, Zhang P, Yang X, Chong T. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma. Aging (Albany NY) 2021;13:11919-41. [PMID: 33952721 DOI: 10.18632/aging.202896] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Hu J, Cai D, Zhao Z, Zhong GC, Gong J. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway. Front Oncol 2021;11:659676. [PMID: 33937074 DOI: 10.3389/fonc.2021.659676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Dunker W, Ye X, Zhao Y, Liu L, Richardson A, Karijolich J. TDP-43 prevents endogenous RNAs from triggering a lethal RIG-I-dependent interferon response. Cell Rep 2021;35:108976. [PMID: 33852834 DOI: 10.1016/j.celrep.2021.108976] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
34 Puvvula PK, Moon AM. Novel Cell-Penetrating Peptides Derived From Scaffold-Attachment- Factor A Inhibits Cancer Cell Proliferation and Survival. Front Oncol 2021;11:621825. [PMID: 33859938 DOI: 10.3389/fonc.2021.621825] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Liu G, Gack MU. Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity. Immunity 2020;53:26-42. [PMID: 32668226 DOI: 10.1016/j.immuni.2020.03.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 40] [Article Influence: 19.0] [Reference Citation Analysis]
36 Chen L, Hu B, Song X, Wang L, Ju M, Li Z, Zhou C, Zhang M, Wei Q, Guan Q, Jiang L, Chen T, Wei M, Zhao L. m6A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma. Front Oncol 2021;11:598017. [PMID: 33796449 DOI: 10.3389/fonc.2021.598017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shen C, Liu J, Yang X, Jiao W, Wang Y. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Front Endocrinol (Lausanne) 2021;12:568397. [PMID: 33692753 DOI: 10.3389/fendo.2021.568397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yang F, Zhao G, Ge L, Song Y, Hong K, Zhang H, Liu C, Hong P, Ma L. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Biomed Res Int 2021;2021:4582082. [PMID: 33628782 DOI: 10.1155/2021/4582082] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Zhang Y, Liu L, Qiu Q, Zhou Q, Ding J, Lu Y, Liu P. Alternative polyadenylation: methods, mechanism, function, and role in cancer. J Exp Clin Cancer Res 2021;40:51. [PMID: 33526057 DOI: 10.1186/s13046-021-01852-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
40 Okude H, Ori D, Kawai T. Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases. Front Immunol 2020;11:625833. [PMID: 33633744 DOI: 10.3389/fimmu.2020.625833] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
41 Shi F, Li Y, Han R, Fu A, Wang R, Nusbaum O, Qin Q, Chen X, Hou L, Zhu Y. Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications. Sci Rep 2021;11:2519. [PMID: 33510252 DOI: 10.1038/s41598-021-81620-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Guo W, Huai Q, Zhang G, Guo L, Song P, Xue X, Tan F, Xue Q, Gao S, He J. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma. Front Oncol 2020;10:598437. [PMID: 33569346 DOI: 10.3389/fonc.2020.598437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
43 Zhou J, Guo Y, Huo Z, Xing Y, Fang J, Ma G, Han Q, Wang M, Xu Q. Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma. Aging (Albany NY) 2021;13:4503-21. [PMID: 33495416 DOI: 10.18632/aging.202411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Lagisquet J, Zuber K, Gramberg T. Recognize Yourself-Innate Sensing of Non-LTR Retrotransposons. Viruses 2021;13:94. [PMID: 33445593 DOI: 10.3390/v13010094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang X, Hu X, Song W, Xu H, Xiao Z, Huang R, Bai Q, Zhang F, Chen Y, Liu Y, Fang J, Li X, Shen Q, Zhao H, Yang X. Mutual dependency between lncRNA LETN and protein NPM1 in controlling the nucleolar structure and functions sustaining cell proliferation. Cell Res 2021;31:664-83. [PMID: 33432115 DOI: 10.1038/s41422-020-00458-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zhang B, Gu Y, Jiang G. Expression and Prognostic Characteristics of m6 A RNA Methylation Regulators in Breast Cancer. Front Genet 2020;11:604597. [PMID: 33362863 DOI: 10.3389/fgene.2020.604597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
47 Sato J, Azuma K, Kinowaki K, Ikeda K, Ogura T, Takazawa Y, Kawabata H, Kitagawa M, Inoue S. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients with Estrogen Receptor-positive Breast Cancer. Clin Breast Cancer. 2020;. [PMID: 33386231 DOI: 10.1016/j.clbc.2020.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Wang Y, Zhang Y, Du Y, Zhou M, Hu Y, Zhang S. Emerging roles of N6-methyladenosine (m6A) modification in breast cancer. Cell Biosci 2020;10:136. [PMID: 33292526 DOI: 10.1186/s13578-020-00502-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
49 Sun Z, Jing C, Xiao C, Li T, Wang Y. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Aging (Albany NY) 2020;12:22078-94. [PMID: 33177247 DOI: 10.18632/aging.104053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
50 Tian Y, Wang J, Qin C, Zhu G, Chen X, Chen Z, Qin Y, Wei M, Li Z, Zhang X, Lv Y, Cai G. Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning. Front Genet 2020;11:566159. [PMID: 33329703 DOI: 10.3389/fgene.2020.566159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
51 Chen M, Nie ZY, Wen XH, Gao YH, Cao H, Zhang SF. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Biosci Rep 2019;39:BSR20192892. [PMID: 31808521 DOI: 10.1042/BSR20192892] [Cited by in Crossref: 34] [Cited by in F6Publishing: 57] [Article Influence: 17.0] [Reference Citation Analysis]
52 Cao R, Zhang J, Jiang L, Wang Y, Ren X, Cheng B, Xia J. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma. Front Oncol 2020;10:1740. [PMID: 32984057 DOI: 10.3389/fonc.2020.01740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Liu W, Zhong C, Lv D, Tang M, Xie F. N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma. Front Genet 2020;11:863. [PMID: 32903675 DOI: 10.3389/fgene.2020.00863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Hu Z, Dong L, Li S, Li Z, Qiao Y, Li Y, Ding J, Chen Z, Wu Y, Wang Z, Huang S, Gao Q, Zhao Y, He X. Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma. Hepatology 2020;72:548-68. [PMID: 31815296 DOI: 10.1002/hep.31062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
55 Di Liddo A, de Oliveira Freitas Machado C, Fischer S, Ebersberger S, Heumüller AW, Weigand JE, Müller-McNicoll M, Zarnack K. A combined computational pipeline to detect circular RNAs in human cancer cells under hypoxic stress. J Mol Cell Biol 2019;11:829-44. [PMID: 31560396 DOI: 10.1093/jmcb/mjz094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
56 Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, Zheng L. RNA-binding proteins in tumor progression. J Hematol Oncol 2020;13:90. [PMID: 32653017 DOI: 10.1186/s13045-020-00927-w] [Cited by in Crossref: 18] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
57 Xu LC, Pan JX, Pan HD. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.Cancer Manag Res. 2020;12:5385-5394. [PMID: 32753956 DOI: 10.2147/CMAR.S254870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
58 Xu N, Chen J, He G, Gao L, Zhang D. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma. J Cancer 2020;11:5187-97. [PMID: 32742465 DOI: 10.7150/jca.41193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
59 Yi L, Wu G, Guo L, Zou X, Huang P. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma. Mol Ther Nucleic Acids 2020;21:299-314. [PMID: 32622331 DOI: 10.1016/j.omtn.2020.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 65] [Article Influence: 13.0] [Reference Citation Analysis]
60 Li J, Rao B, Yang J, Liu L, Huang M, Liu X, Cui G, Li C, Han Q, Yang H, Cui X, Sun R. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma. Front Oncol 2020;10:769. [PMID: 32582536 DOI: 10.3389/fonc.2020.00769] [Cited by in Crossref: 13] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
61 Zhuang Z, Chen L, Mao Y, Zheng Q, Li H, Huang Y, Hu Z, Jin Y. Diagnostic, progressive and prognostic performance of m6A methylation RNA regulators in lung adenocarcinoma. Int J Biol Sci 2020;16:1785-97. [PMID: 32398949 DOI: 10.7150/ijbs.39046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
62 Lu X, Qiao L, Liu Y. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1. J Cell Biochem 2020;121:4064-73. [PMID: 31930565 DOI: 10.1002/jcb.29579] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
63 Wright Muelas M, Mughal F, O'Hagan S, Day PJ, Kell DB. The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data. Sci Rep 2019;9:17960. [PMID: 31784565 DOI: 10.1038/s41598-019-54288-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
64 Yan M, Sun L, Li J, Yu H, Lin H, Yu T, Zhao F, Zhu M, Liu L, Geng Q, Kong H, Pan H, Yao M. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. J Exp Clin Cancer Res 2019;38:478. [PMID: 31775888 DOI: 10.1186/s13046-019-1479-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zhang S, Wu X, Diao P, Wang C, Wang D, Li S, Wang Y, Cheng J. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. J Cell Physiol 2020;235:4804-13. [DOI: 10.1002/jcp.29357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
66 Koedoot E, Wolters L, van de Water B, Dévédec SEL. Splicing regulatory factors in breast cancer hallmarks and disease progression. Oncotarget 2019;10:6021-37. [PMID: 31666932 DOI: 10.18632/oncotarget.27215] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
67 Liu L, Liu X, Dong Z, Li J, Yu Y, Chen X, Ren F, Cui G, Sun R. N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival. J Cancer 2019;10:5447-59. [PMID: 31632489 DOI: 10.7150/jca.35053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 51] [Article Influence: 9.7] [Reference Citation Analysis]
68 Wu Q, Li P, Wu M, Liu Q. Deregulation of Circular RNAs in Cancer From the Perspectives of Aberrant Biogenesis, Transport and Removal. Front Genet 2019;10:16. [PMID: 30774645 DOI: 10.3389/fgene.2019.00016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
69 Manipur I, Granata I, Guarracino MR. Exploiting single-cell RNA sequencing data to link alternative splicing and cancer heterogeneity: A computational approach. Int J Biochem Cell Biol 2019;108:51-60. [PMID: 30633986 DOI: 10.1016/j.biocel.2018.12.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
70 Sarbanes SL, Le Pen J, Rice CM. Friend and foe, HNRNPC takes on immunostimulatory RNAs in breast cancer cells. EMBO J 2018;37:e100923. [PMID: 30389667 DOI: 10.15252/embj.2018100923] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]